HomeCompareCLBTW vs ARCC

CLBTW vs ARCC: Dividend Comparison 2026

CLBTW yields 38.11% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLBTW wins by $2.4K in total portfolio value
10 years
CLBTW
CLBTW
● Live price
38.11%
Share price
$5.25
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$27.0K
Annual income
$5.10
Full CLBTW calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — CLBTW vs ARCC

📍 CLBTW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLBTWARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLBTW + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLBTW pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLBTW
Annual income on $10K today (after 15% tax)
$3,238.96/yr
After 10yr DRIP, annual income (after tax)
$4.34/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, CLBTW beats the other by $3.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLBTW + ARCC for your $10,000?

CLBTW: 50%ARCC: 50%
100% ARCC50/50100% CLBTW
Portfolio after 10yr
$25.8K
Annual income
$3.13/yr
Blended yield
0.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

CLBTW
No analyst data
Altman Z
2.7
Piotroski
5/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLBTW buys
0
ARCC buys
0
No recent congressional trades found for CLBTW or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLBTWARCC
Forward yield38.11%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%-50%
Portfolio after 10y$27.0K$24.5K
Annual income after 10y$5.10$1.16
Total dividends collected$4.3K$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CLBTW vs ARCC ($10,000, DRIP)

YearCLBTW PortfolioCLBTW Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$12,605$1,905.27$11,381$541.15+$1.2KCLBTW
2$14,610$1,122.26$12,621$284.08+$2.0KCLBTW
3$16,240$607.82$13,827$145.31+$2.4KCLBTW
4$17,693$315.73$15,062$73.43+$2.6KCLBTW
5$19,092$160.73$16,364$36.89+$2.7KCLBTW
6$20,510$81.05$17,757$18.49+$2.8KCLBTW
7$21,986$40.68$19,258$9.25+$2.7KCLBTW
8$23,545$20.38$20,880$4.63+$2.7KCLBTW
9$25,204$10.20$22,636$2.32+$2.6KCLBTW
10$26,973$5.10$24,539$1.16+$2.4KCLBTW

CLBTW vs ARCC: Complete Analysis 2026

CLBTWStock

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company was incorporated in 1999 and is headquartered in Petah Tikva, Israel.

Full CLBTW Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this CLBTW vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLBTW vs SCHDCLBTW vs JEPICLBTW vs OCLBTW vs KOCLBTW vs MAINCLBTW vs HTGCCLBTW vs GBDCCLBTW vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.